221
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Profile of Addicted Patients Who Reenter Treatment Programs

, PhD, , PhD, , PhD & , BSc

REFERENCES

  • Hussaarts P, Roozen HG, Meyers RJ, van de Wetering BJM, McCrady BS. Problem areas reported by substance abusing individuals and their concerned significant others. Am J Addict. 2012;21:38–46.
  • Carroll KM, Rounsaville BJ. On beyond urine: clinically useful assesment instruments in the treatment of drug dependence. Behav Res Ther. 2002;40:1329–1344.
  • Ana EJS, Martino S, Ball SA, Nich C, Frankforter TL, Carroll KM. What is usual about “treatment-as-usual”? Data from two multisite effectiveness trials. J Subst Abuse Treat. 2008;35:369–379.
  • López-Goñi JJ, Fernández-Montalvo J, Menéndez JC, Yudego F, García AR, Esarte S. Group and individual change in the treatment of drug addictions: a follow-up study in Therapeutic Communities. Span J Psychol. 2010;13:906–913.
  • López-Goñi JJ, Fernández-Montalvo J, Illescas C, Landa N, Lorea I. Determining socio-demographic predictors of treatment dropout: results in a therapeutic community. Int J Soc Welfare. 2008;17:374–378.
  • Sánchez-Hervás E, Secades R, Santonja FJ, et al. Abandono del tratamiento en adictos a la cocaína. Adicciones. 2010;22:59–64.
  • Grella CE, Hser YI, Joshi V, Douglas Anglin M. Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug Alcohol Depend. 1999;57:151–166.
  • Ravndal E, Vaglum P, Lauritzen G. Completion of long-term inpatient treatment of drug abusers: a prospective study from 13 different units. Eur Addict Res. 2005;11:180–185.
  • Fernández-Montalvo J, López-Goñi JJ, Illescas C, Landa N, Lorea I. Evaluation of a therapeutic community treatment program: a long-term follow-up study in Spain. Subst Use Misuse. 2008;43:1362–1377.
  • Fernández-Montalvo J, López-Goñi JJ, Illescas C, Landa N, Lorea I. Relapse precipitants in addictions: results in a therapeutic community. J Addict Dis. 2007;27:55–61.
  • Dennis ML, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007;4:45–55.
  • Hser Y, Longshore D, Anglin MD. The life course perspective on drug use. A conceptual framework for undestanding drug use trajectories. Eval Rev. 2007;31:515–547.
  • Scott CK, Dennis ML, Foss MA. Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry, and recovery. Drug Alcohol Depend. 2005;78:325–338.
  • Dennis ML, Scott CK, Funk R, Foss MA. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 2005;28:S51–S62.
  • Rush BR, Dennis ML, Scott CK, Castel S, Funk RR. The interaction of co-occurring mental disorders and recovery management checkups on substance abuse treatment participation and recovery. Eval Rev. 2008;32:7–38.
  • Dennis ML, Scott CK, Funk R. An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders. Eval Program Plann. 2003;26:339–352.
  • Scott CK, Dennis ML. Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users. Addiction. 2009;104:959–971.
  • Lash SJ, Timko C, Curran GM, McKay JR, Burden JL. Implementation of evidence-based substance use disorder continuing care interventions. Psychol Addict Behav. 2011;25:238–251.
  • Dennis ML, French MT, McCollister KE, Scott CK. The economic costs of quarterly monitoring and recovery management checkups for adults with chronic substance use disorders. J Subst Abuse Treat. 2011;41:201–207.
  • Hser Y, Grella CE, Hsieh S, Anglin MD, Brown BS. Prior treatment experience related to process and outcom in DATOS. Drug Alcohol Depend. 1999;57:137–150.
  • Hser Y, Joshi V, Anglin MD, Fletcher B. Predicting posttreatment cocaine abstinence for first-time admissions and treatment repeaters. Am J Public Health. 1999;89:666–671.
  • Cacciola JS, Leggett K, Camilleri AC. Treatment history: relationship to treatment outcomes. Subst Use Misuse. 2009;44:305–321.
  • Moos RH, Moos BS, Finney JW. Predictors of deterioration among patients with substance-use disorders. J Clin Psychol. 2001;57:1403–1419.
  • Lejuez CW, Zvolensky MJ, Daughters SB, et al. Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behav Res Ther. 2008;46:811–818.
  • Fernández-Montalvo J, López-Goñi JJ. Comparison of completers and dropouts in psychological treatment for cocaine addiction. Addict Res Theory. 2010;18:433–441.
  • Aharonovich E, Hasin DS, Brooks AC, Liu XH, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 2006;81:313–322.
  • Streeter CC, Terhune DB, Whitfield TH, et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2008;33:827–836.
  • Fernández-Montalvo J, López-Goñi JJ, Landa N, Illescas C, Lorea I, Zarzuela A. Trastornos de personalidad y abandonos terapéuticos en pacientes adictos: resultados en una comunidad terapéutica. Int J Clin Health Psychol. 2004;4:271–283.
  • Chan Y-F, Dennis ML, Funk RR. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat. 2008;34:14–24.
  • López-Goñi JJ, Fernández-Montalvo J, Arteaga A. Predictive validity of the EuropAsi: clinical diagnosis or composite scoring? J Subst Abuse Treat. 2012;42:392–399.
  • Kokkevi A, Hartgers C. European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. 1995;1:208–210.
  • McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26–33.
  • Koeter MWJ, Hartgers C. European Addiction Severity Index EuropASI. Cost a6. Preliminary Procedure for the Computation of the EuropASI Composite Scores. Amsterdam: The Amsterdam Institute for Addiction Research; 1997.
  • Bobes J, González MP, Saiz PA, Bousoño M. Índice Europeo de Severidad de la Adicción: EuropASI. Versión española [European Index of Severity of Addiction: EuropASI. Spanish Version]. Paper presented at IV Reunión Interregional de Psiquiatría; Gijon; . April 1996.
  • Derogatis LR. The SCL-90-R. Baltimore: Clinical Psychometric Research; 1992.
  • González de Rivera JL. Versión española del SCL-90-R. Madrid: TEA; 2002.
  • Millon T. Millon Clinical Multiaxial Inventory-II (MCMI II). Minneapolis, MN: National Computer Systems; 1997.
  • Weltzer SJ. The Millon Clinical Multiaxial Inventory (MCMI): a review. J Pers Assess. 1990:445–464.
  • López-Goñi JJ, Fernández-Montalvo J, Arteaga A. Addiction treatment dropout: exploring patients’ characteristics. Am J Addict. 2012;21:78–85.
  • Lorea I, Fernández-Montalvo J, Tirapu-Ustarroz J, Landa N, López-Goñi J. Rendimiento neuropsicológico en la adicción a la cocaína: una revisión crítica [Neuropsychological performance in cocaine addiction: a critical review]. Rev Neurol. 2010;51:412–426.
  • Martos MJ, Pozo C. Apoyo funcional vs. disfuncional en una muestra de pacientes crónicos. Su incidencia sobre la salud y el cumpli-miento terapéutico. [Functional versus non-functional social support in a sample of chronic patients. Repercussion on health and treatment compliance]. An Psicol. 2011;27:47–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.